nodes	percent_of_prediction	percent_of_DWPC	metapath
MACITENTAN—EDNRB—Endothelin Pathways—ECE1—amyotrophic lateral sclerosis	0.103	0.135	CbGpPWpGaD
MACITENTAN—EDNRA—Endothelin Pathways—ECE1—amyotrophic lateral sclerosis	0.0737	0.097	CbGpPWpGaD
MACITENTAN—EDNRB—Prostaglandin Synthesis and Regulation—PLA2G4A—amyotrophic lateral sclerosis	0.0354	0.0465	CbGpPWpGaD
MACITENTAN—EDNRB—Peptide GPCRs—C5AR1—amyotrophic lateral sclerosis	0.0348	0.0458	CbGpPWpGaD
MACITENTAN—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.0334	0.139	CcSEcCtD
MACITENTAN—EDNRA—Prostaglandin Synthesis and Regulation—PLA2G4A—amyotrophic lateral sclerosis	0.0253	0.0333	CbGpPWpGaD
MACITENTAN—EDNRA—Peptide GPCRs—C5AR1—amyotrophic lateral sclerosis	0.0249	0.0327	CbGpPWpGaD
MACITENTAN—Influenza—Riluzole—amyotrophic lateral sclerosis	0.0221	0.092	CcSEcCtD
MACITENTAN—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.0212	0.0885	CcSEcCtD
MACITENTAN—EDNRB—Prostaglandin Synthesis and Regulation—PTGS2—amyotrophic lateral sclerosis	0.0199	0.0262	CbGpPWpGaD
MACITENTAN—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.0197	0.082	CcSEcCtD
MACITENTAN—Infestation—Riluzole—amyotrophic lateral sclerosis	0.0197	0.082	CcSEcCtD
MACITENTAN—EDNRB—Endothelins—PLA2G4A—amyotrophic lateral sclerosis	0.0195	0.0257	CbGpPWpGaD
MACITENTAN—CYP2C19—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.0193	0.0254	CbGpPWpGaD
MACITENTAN—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.0191	0.0798	CcSEcCtD
MACITENTAN—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.0175	0.0731	CcSEcCtD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—C5AR1—amyotrophic lateral sclerosis	0.0164	0.0215	CbGpPWpGaD
MACITENTAN—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.016	0.0668	CcSEcCtD
MACITENTAN—EDNRA—Prostaglandin Synthesis and Regulation—PTGS2—amyotrophic lateral sclerosis	0.0143	0.0188	CbGpPWpGaD
MACITENTAN—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.0142	0.0593	CcSEcCtD
MACITENTAN—EDNRA—Endothelins—PLA2G4A—amyotrophic lateral sclerosis	0.014	0.0184	CbGpPWpGaD
MACITENTAN—Oedema—Riluzole—amyotrophic lateral sclerosis	0.0126	0.0523	CcSEcCtD
MACITENTAN—Infection—Riluzole—amyotrophic lateral sclerosis	0.0125	0.052	CcSEcCtD
MACITENTAN—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.0123	0.0513	CcSEcCtD
MACITENTAN—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0489	CcSEcCtD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—C5AR1—amyotrophic lateral sclerosis	0.0117	0.0154	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.011	0.0144	CbGpPWpGaD
MACITENTAN—ALB—HDL-mediated lipid transport—APOE—amyotrophic lateral sclerosis	0.00953	0.0125	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.00835	0.011	CbGpPWpGaD
MACITENTAN—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00832	0.011	CbGpPWpGaD
MACITENTAN—Headache—Riluzole—amyotrophic lateral sclerosis	0.00787	0.0328	CcSEcCtD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.00785	0.0103	CbGpPWpGaD
MACITENTAN—ALB—Platelet degranulation—TUBA4A—amyotrophic lateral sclerosis	0.00777	0.0102	CbGpPWpGaD
MACITENTAN—ALB—Response to elevated platelet cytosolic Ca2+—TUBA4A—amyotrophic lateral sclerosis	0.00741	0.00975	CbGpPWpGaD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—C3—amyotrophic lateral sclerosis	0.00714	0.00939	CbGpPWpGaD
MACITENTAN—ALB—Platelet degranulation—PFN1—amyotrophic lateral sclerosis	0.007	0.00921	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.00693	0.00912	CbGpPWpGaD
MACITENTAN—ALB—Response to elevated platelet cytosolic Ca2+—PFN1—amyotrophic lateral sclerosis	0.00667	0.00878	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.00598	0.00787	CbGpPWpGaD
MACITENTAN—ALB—Lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.00547	0.0072	CbGpPWpGaD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—C3—amyotrophic lateral sclerosis	0.00511	0.00672	CbGpPWpGaD
MACITENTAN—CYP2C19—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.00505	0.00664	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—SOD1—amyotrophic lateral sclerosis	0.00485	0.00638	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.00479	0.0063	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.00472	0.00621	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.00429	0.00564	CbGpPWpGaD
MACITENTAN—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—amyotrophic lateral sclerosis	0.00426	0.00561	CbGpPWpGaD
MACITENTAN—CYP2C19—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00397	0.00522	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—SOD1—amyotrophic lateral sclerosis	0.00395	0.00519	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.00365	0.0048	CbGpPWpGaD
MACITENTAN—ALB—Lipid and lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.00364	0.00479	CbGpPWpGaD
MACITENTAN—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00359	0.00473	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—APOE—amyotrophic lateral sclerosis	0.00358	0.00471	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	0.00345	0.00454	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.00343	0.00451	CbGpPWpGaD
MACITENTAN—ALB—Platelet degranulation—SOD1—amyotrophic lateral sclerosis	0.00338	0.00445	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.00338	0.00445	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.00334	0.0044	CbGpPWpGaD
MACITENTAN—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—amyotrophic lateral sclerosis	0.00322	0.00424	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.00314	0.00413	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.00314	0.00413	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	0.00311	0.00409	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00308	0.00405	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.00307	0.00404	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.00298	0.00392	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.00288	0.0038	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00282	0.00371	CbGpPWpGaD
MACITENTAN—ALB—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00282	0.0037	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00277	0.00364	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00262	0.00345	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.00261	0.00343	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.00256	0.00337	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.00256	0.00337	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.00253	0.00333	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00253	0.00333	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00246	0.00324	CbGpPWpGaD
MACITENTAN—ALB—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00239	0.00315	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.00239	0.00315	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00235	0.00309	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.00225	0.00296	CbGpPWpGaD
MACITENTAN—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.00224	0.00294	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00222	0.00292	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00221	0.00291	CbGpPWpGaD
MACITENTAN—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00216	0.00284	CbGpPWpGaD
MACITENTAN—ALB—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00213	0.00281	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.00213	0.0028	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.00212	0.00279	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.00206	0.00272	CbGpPWpGaD
MACITENTAN—ALB—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	0.00206	0.00272	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.00206	0.00271	CbGpPWpGaD
MACITENTAN—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	0.00197	0.00259	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.00187	0.00246	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.00183	0.00241	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.00181	0.00238	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.00178	0.00234	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.00174	0.00229	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00169	0.00222	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.00165	0.00217	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.00163	0.00215	CbGpPWpGaD
MACITENTAN—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00161	0.00211	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.0016	0.00211	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.00159	0.00209	CbGpPWpGaD
MACITENTAN—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00159	0.00209	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.00155	0.00205	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00152	0.00199	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.00152	0.00199	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.0015	0.00198	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.00147	0.00194	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00143	0.00188	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00137	0.00181	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00137	0.00181	CbGpPWpGaD
MACITENTAN—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	0.00135	0.00177	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.00135	0.00177	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.00134	0.00176	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.00133	0.00175	CbGpPWpGaD
MACITENTAN—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	0.00128	0.00169	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00128	0.00168	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00125	0.00165	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.00125	0.00165	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.00125	0.00164	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00123	0.00162	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00123	0.00162	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00122	0.0016	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00122	0.0016	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	0.00119	0.00156	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.00117	0.00154	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00117	0.00154	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00115	0.00151	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00113	0.00148	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.00111	0.00146	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.00111	0.00145	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	0.0011	0.00144	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00108	0.00143	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00105	0.00138	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.00103	0.00135	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	0.000992	0.00131	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000985	0.0013	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000967	0.00127	CbGpPWpGaD
MACITENTAN—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000953	0.00125	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000952	0.00125	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	0.000915	0.0012	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000895	0.00118	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	0.00089	0.00117	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.00085	0.00112	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000791	0.00104	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000774	0.00102	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000752	0.000989	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000741	0.000975	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000741	0.000975	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000736	0.000969	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000694	0.000913	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	0.000694	0.000913	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000677	0.000891	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000675	0.000888	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000655	0.000861	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000632	0.000831	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00063	0.000829	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	0.000623	0.000819	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000619	0.000814	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000609	0.000801	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.000598	0.000787	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000592	0.000779	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00057	0.00075	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000567	0.000746	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.000555	0.000731	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	0.000535	0.000705	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.00052	0.000684	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000511	0.000673	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000472	0.000621	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000468	0.000616	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000467	0.000614	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000443	0.000583	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—TP53—amyotrophic lateral sclerosis	0.00042	0.000552	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000406	0.000534	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.000398	0.000523	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	0.000375	0.000493	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000356	0.000469	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.00032	0.000421	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.000308	0.000406	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000308	0.000405	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000306	0.000403	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—TP53—amyotrophic lateral sclerosis	0.0003	0.000395	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000281	0.00037	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000275	0.000362	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000253	0.000332	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000233	0.000306	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	0.000232	0.000305	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	0.000208	0.000273	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000165	0.000217	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000159	0.000209	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000152	0.0002	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000142	0.000187	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	0.000125	0.000164	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.56e-05	0.000113	CbGpPWpGaD
